Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Center for Evidence-Based Management. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Center for Evidence-Based Management or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Module 14 Assess - evaluate the outcome of the decision taken

28:56
 
Share
 

Manage episode 329694760 series 3334232
Content provided by Center for Evidence-Based Management. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Center for Evidence-Based Management or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

This episode accompanies Module 14 of the course, which is about evaluating the outcome of the decision we’ve taken or the solution we implemented. This is the last stage of our evidence-based management process and is vital to ensuring that we learn from what we’ve done.
Assessing outcomes is vital, because otherwise, how do we know if what we did was effective, and how can we learn and develop our approach to decision making? Did we capture a baseline before the decision was implemented? And was the decision implemented as planned? If we assess outcomes without these two, then conclusions could be very suspect.
We continue our case study of the large trial at pharmaceutical organization Sandoz (part of Novartis Group), and find out how the D&I interventions were assessed.
Denise Rousseau's 2020 paper: Making Evidence based organisational decisions in an uncertain world
After action review paper: https://www.cebma.org/wp-content/uploads/Guide-to-the-after_action_review.pdf

Host: Karen Plum
Guests:

Additional speaker, courtesy of CIPD: Niamh McNamara, Global Head of People & Organisation, Novartis
Find out more about the course here: https://cebma.org/resources-and-tools/course-modules/

  continue reading

18 episodes

Artwork
iconShare
 
Manage episode 329694760 series 3334232
Content provided by Center for Evidence-Based Management. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Center for Evidence-Based Management or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

This episode accompanies Module 14 of the course, which is about evaluating the outcome of the decision we’ve taken or the solution we implemented. This is the last stage of our evidence-based management process and is vital to ensuring that we learn from what we’ve done.
Assessing outcomes is vital, because otherwise, how do we know if what we did was effective, and how can we learn and develop our approach to decision making? Did we capture a baseline before the decision was implemented? And was the decision implemented as planned? If we assess outcomes without these two, then conclusions could be very suspect.
We continue our case study of the large trial at pharmaceutical organization Sandoz (part of Novartis Group), and find out how the D&I interventions were assessed.
Denise Rousseau's 2020 paper: Making Evidence based organisational decisions in an uncertain world
After action review paper: https://www.cebma.org/wp-content/uploads/Guide-to-the-after_action_review.pdf

Host: Karen Plum
Guests:

Additional speaker, courtesy of CIPD: Niamh McNamara, Global Head of People & Organisation, Novartis
Find out more about the course here: https://cebma.org/resources-and-tools/course-modules/

  continue reading

18 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play